(2 years, 7 months ago)
Commons ChamberI know from discussions with constituents that needle phobias are a real thing. Will my right hon. Friend therefore tell the House what support the Government are giving to intranasal vaccine delivery systems to ensure that the maximum number of people take up the vaccine?
The Department of Health and Social Care commissioned research through the National Institute for Health and Care Research, co-funded with UK Research and Innovation, for an Imperial College London study, worth £580,000, looking specifically at the safety and effectiveness of two covid-19 vaccines administered by respiratory tract. The study is ongoing, but it is in the later stages of the phase one clinical trial, and the results will be made public in due course, following peer review.
(2 years, 11 months ago)
Commons ChamberAs I understand it, the location of vaccination sites in the devolved nations is the responsibility of those nations. I can only speak for England in that regard, so the hon. Gentleman may wish to take the matter up with the Minister of Health in Northern Ireland.
May I take this opportunity to put on record my thanks to my daughter, and to all her colleagues across the NHS who have worked on the frontline throughout the pandemic, caring for those who have sadly needed hospital treatment?
I have been very supportive of the Government’s approach to the pandemic and their actions, but I tend to agree that as the facts change, we should change our approach. What we have learnt about omicron is that the rationale behind mandatory vaccination has now shifted from protecting others to protecting oneself. Should we not revisit that, given the figures that the Minister has been quoting about the vaccination status of those in hospital and in intensive care units?
When we protect ourselves by having a vaccination, we protect others. My hon. Friend mentioned omicron, but we have seen other variants before, and we will no doubt see more in the future.